Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Marcaine for pain after abdominoplasty or TRAM flap
NCT02542956Phase 4Withdrawn
- Sponsor
- Henry Ford Health
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Henry Ford Health. Planned start Oct 2014; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02542956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542956.